Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Double urologic tumors: reduced immunocompetence?].

K F Klippel, G Hutschenreiter, G Jacobi

    Onkologie
    |February 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Practical aspects of ketamine treatment-Safety, combination treatment and comorbidities].

    Der Nervenarzt·2022
    Same author

    Billing and up coding: What's a doctor-patient to do?

    International journal of women's dermatology·2017
    Same author

    Chenodeoxycholic acid stimulated fibroblast growth factor 19 response - a potential biochemical test for bile acid diarrhoea.

    Alimentary pharmacology & therapeutics·2017
    Same author

    Percutaneous Stone Manipulation.

    The Journal of urology·2016
    Same author

    Dark starvation and chloroplast function : I. The decrease of enzyme activities correlated with NADP reduction and their regeneration by light.

    Planta·2014
    Same author

    [Comparative studies on the lipid composition of etioplasts and chloroplasts from Pisum and of chloroplasts from an Aurea mutant of Nicotiana].

    Planta·2014
    Same journal

    Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma.

    Onkologie·2013
    Same journal

    Metastatic germ cell tumour following renal transplantation.

    Onkologie·2013
    Same journal

    miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.

    Onkologie·2013
    Same journal

    A meta-analysis of internal mammary lymph node metastasis in breast cancer patients.

    Onkologie·2013
    Same journal

    Patient-related delay in presentation for cutaneous squamous cell carcinoma. A cross-sectional clinical study.

    Onkologie·2013
    Same journal

    Treatment of primary breast cancer at the surgical unit of the Charité 1984-1998.

    Onkologie·2013
    See all related articles

    Patients with primary multiple neoplasias and solitary tumors show reduced immune function. Both cancer groups had diminished immunocompetence compared to healthy individuals, indicating a link between cancer and immune system impairment.

    Area of Science:

    • Immunology
    • Oncology

    Background:

    • Primary multiple neoplasias (PMN) represent a complex oncological challenge.
    • Assessing immune status is crucial for understanding cancer progression and patient outcomes.

    Purpose of the Study:

    • To evaluate the immunocompetence of patients with primary multiple neoplasias.
    • To compare immune status between patients with multiple tumors, solitary tumors, and healthy controls.

    Main Methods:

    • Immunostaging including immunoglobulin levels, B- and T-lymphocyte counts.
    • Lymphocyte stimulation assays (ConA, PWM, PHA) and DNCB-epidermal testing were performed.

    Main Results:

    • No significant immune differences were found between patients with primary multiple neoplasias and those with solitary tumors.

    Related Experiment Videos

  • Both cancer patient groups exhibited significantly diminished immunocompetence compared to the non-malignant control group.

    • Conclusions:

    • Primary multiple neoplasias do not present a distinct immune profile compared to solitary tumors.
    • Cancer, in general, is associated with a compromised immune system, impacting both multiple and solitary tumor patients.